Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease.
With growing drug resistance the epidemic remains and will require significant attention and …

Purpose of review Tuberculous meningitis (TBM) is a global health problem. In this review,
we systematically evaluate the evidence for current and emerging antimicrobials, host …

Background Tuberculosis causes more deaths than any other infectious disease worldwide,
with pulmonary tuberculosis being the most common form. Standard first‐line treatment for …

Objective: This study aims to systematically review the content and potential effects of
clinical pharmacy services in tuberculosis (TB) care management. Methods: Searches were …

• Most patients with TB disease should be initiated on a regimen of isoniazid, rifampin,
pyrazinamide and ethambutol until results of genotypic or phenotypic drug susceptibility are …

Background Dosages of anti-tuberculosis (TB) drugs are recommended to be adjusted
according to renal function for patients complicated with chronic kidney disease (CKD) …

Objectives To evaluate and update the evidence on the comparative efficacy and safety of
antimicrobial drugs regimens for treating pulmonary drug-susceptible tuberculosis (DS-TB) …

Isoniazid resistant Mycobacterium tuberculosis (Hr-TB) is the most frequently encountered
TB resistance phenotype in North America but limited data exist on the effectiveness of …

Источниками инфекции при туберкулезе могут быть:► больной туберкулезом
человек;► животные (чаще крупный рогатый скот, козы) и птицы, больные …

Background Relapse/refractory B-cell acute lymphoblastic leukaemia (r/r B-ALL) represents
paediatric cancer with a challenging prognosis. CAR T-cell treatment, considered an …